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Abstract
Background: The serine/threonine protein kinase B (PKB/Akt) is involved in insulin signaling, cellular survival, and
transformation. Carboxyl-terminal modulator protein (CTMP) has been identified as a novel PKB binding partner in a
yeast two-hybrid screen, and appears to be a negative PKB regulator with tumor suppressor-like properties. In the
present study we investigate novel mechanisms by which CTMP plays a role in apoptosis process.
Results: CTMP is localized to mitochondria. Furthermore, CTMP becomes phosphorylated following the treatment of
cells with pervanadate, an insulin-mimetic. Two serine residues (Ser37 and Ser38) were identified as novel in vivo
phosphorylation sites of CTMP. Association of CTMP and heat shock protein 70 (Hsp70) inhibits the formation of
complexes containing apoptotic protease activating factor 1 and Hsp70. Overexpression of CTMP increased the
sensitivity of cells to apoptosis, most likely due to the inhibition of Hsp70 function.
Conclusion: Our data suggest that phosphorylation on Ser37/Ser38 of CTMP is important for the prevention of
mitochondrial localization of CTMP, eventually leading to cell death by binding to Hsp70. In addition to its role in PKB
inhibition, CTMP may therefore play a key role in mitochondria-mediated apoptosis by localizing to mitochondria.
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Background
Protein kinase B (PKB/Akt) is activated by receptor tyro-
sine kinases and regulates cell proliferation, survival, and
motility [1,2]. PKB activation occurs when PtdIns[3-5]P3
(a product of PI3K) binds to the pleckstrin homology
domain of PKB. Phosphorylation of two amino acids
(Thr308 and Ser473) is then required for full PKB activa-
tion [3,4]. Unphosphorylated PKB is inactive, but PKB
phosphorylation on Thr308 (by PDK1) stimulates PKB
activity by approximately 100-fold [2]. Phosphorylation
on a second regulatory site at the carboxyl terminus
(Ser473; termed the hydrophobic motif) by rictor-mTOR
and DNA-PK can further activate PKB seven- to ten-fold
([5-7]. The crystal structure of PKB suggests that Ser473
phosphorylation is important for kinase activation and
stabilization [8,9].
Recently, C-terminal modulator protein (CTMP) was
identified as a PKB binding partner [10]. CTMP overex-
pression inactivates PKB in v-Akt-transformed cells trans-
planted into mice [10], in cultured cells [11], and in a K-
ras-induced lung cancer model [12]. The tumor suppres-
sor-like properties of CTMP are supported by a report
demonstrating inhibition of CTMP expression by hyper-
methylation of its promoter in malignant glioblastomas,
where PKB activity is frequently altered [13].
Mitochondria regulate cellular energy supplies, apoptosis,
and signaling pathways. Alterations in mitochondrial
function are responsible for a range of inherited and
acquired human diseases and are implicated in the aging
process [14]. Cytosolic mitochondrial protein precursors
contain information that is necessary to direct them to the
mitochondria. Mitochondrial precursor proteins in the
cytosol are present as complexes with factors that stabilize
them, as they are prone to degradation and aggregation.
Several such factors are implicated as cytosolic chaper-
ones; however, convincing data exist only for heat shock
protein 70 (Hsp70) and Hsp90 [15,16].
Here, we describe CTMP phosphorylation on two sites fol-
lowing treatment with pervanadate, an insulin-mimetic.
Surprisingly, CTMP C-terminally tagged with GFP was
localized to mitochondria, whereas CTMP N-terminally
tagged with GFP was mainly found in the cytoplasm. Con-
sistent with this observation, mitochondrial localization
of endogenous and exogenous CTMP has recently been
reported [17] while this study was in review. Mitochon-
drial localization of CTMP was dependent on an N-termi-
nal mitochondrial targeting sequence (MTS) and was
inhibited by phosphorylation on Ser37/Ser38. Finally,
CTMP overexpression sensitizes the cell to apoptosis by
sequestering Hsp70 away from apoptotic protease activat-
ing factor 1 (Apaf-1), suggesting that CTMP is involved in
apoptotic processes through its mitochondrial localiza-
tion and binding to Hsp70.
Results
Identification of phosphorylated residues of CTMP in 
pervanadate-stimulated CCL64 cells
We previously observed CTMP phosphorylation upon
pervanadate treatment in cells stably expressing Flag-
CTMP [10], prompting us to map the phosphorylation
sites in CTMP. Flag-CTMP was isolated from 32P-metabol-
ically labeled cells prior to pervanadate treatment. Autora-
diography after SDS-PAGE showed that CTMP
phosphorylation was higher in pervanadate-treated cells
versus untreated (Figure 1A). Phosphoamino acid analy-
sis of total protein revealed this 3-fold increase of 32P-
incorporation was predominantly due to serine phospho-
rylation (Figure 1B). Bands corresponding to Flag-CTMP
were excised and digested with trypsin. The resultant mix-
ture of peptides was separated on a C18 column by HPLC.
The UV-trace, as well as the peptide masses detected was
very similar between two samples whereas the radiola-
beled phosphopeptide abundance derived from pervana-
date treated cells was markedly increased compared to
control cells (data not shown). Fractions with higher radi-
oactivity were further analyzed by NanoESI-MS/MS [18].
The NanoESI-MS/MS measures the mass to charge ratio
(m/z) of each peptide in the mixture that, upon fragmen-
tation, liberates a species with a m/z of 79 Da (correspond-
ing to a single phosphate group) allowing detection of
phosphopeptides among other peptides in each fraction.
An example of the specificity is shown for fraction 16 from
pervanadate-treated cells (Figure 1D). Approximately 20
peptides were detected by NanoESI-MS in the positive full
scan mode (Figure 1C); however, only one phosphopep-
tide was detected in the m/z 79 precursor scan mode  (Fig-
ure 1D). The observed m/z value of 607 accounted for the
CTMP-derived peptide SF SSEEVILK (35–44 a.a.), which
was 80 Da heavier than expected for the non-phosphor-
ylated form based on phosphorylation at one residue. To
precisely locate the phosphorylation site of this phos-
phopeptide, CID tandem MS was performed [19]. The
CID tandem MS clearly showed the phosphate was
located on either Ser37 or Ser38, but not at both residues,
based on the observed mass (1218 Da). Since we detected
the ions y6 (m/z 730), y7 (m/z 817), (indicating Ser37 was
phosphorylated (Figure 1E)), as well as the ions y6 (m/z
730), y7 (m/z 897), and y7-H3PO4 (m/z799), (suggesting
Ser38 was phosphorylated (Figure 1F)), we concluded this
fraction probably contained a mixture of the peptide
phosphorylated at either Ser37 or Ser38.
CTMP is localized to the mitochondrial intermembrane 
space and/or matrix
We previously reported that CTMP localized to the plasma
membrane, leading to PKB inhibition [10]. Analysis of the
CTMP sequence using the PSORTII prediction algorithm
[20] indicated CTMP had a 69.6% probability for mito-
chondrial localization with a 21.7% probability for cyto-
plasm localization. These findings were also supported byBMC Cell Biology 2009, 10:53 http://www.biomedcentral.com/1471-2121/10/53
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TargetP V1.0 [21] and MitoProt II 1.0a4 [22]. Therefore,
CTMP subcellular localization in U2OS cells was exam-
ined using GFP-NT-CTMP [10], since U2OS cells exhibit
epithelial adherent morphology and are convenient for
localization studies. Confocal imaging analysis revealed
that 92% of cells expressed GFP-NT-CTMP in the cyto-
plasm, with a smaller amount of cells (8%) expressing
GFP-NT-CTMP at the plasma membrane (Figure 2A). GFP
C-terminal tagged CTMP were also prepared to explore
the possibility that the GFP tag at the N-terminus affected
mitochondrial localization of CTMP [23]. Strikingly,
about 46% of cells expressed GFP-CT-CTMP in the mito-
chondria, with 32% of cells expressing GFP-CT-CTMP at
the mitochondria and cytoplasm (Figure 2B), indicating
that CTMP may localize to the mitochondria. We con-
firmed these findings using DsRed-mito as a mitochon-
drial marker, which co-localized with GFT-CT-CTMP
(Figure 2C). Additional biochemical analysis, using cell
fractionation, indicated CTMP was present in both the
mitochondria and cytoplasm (Figure 2D). Since all exper-
Serine 37 or Serine 38 of CTMP is phosphorylated in vivo fol- lowing stimulation of CCL64 cells with pervanadate Figure 1
Serine 37 or Serine 38 of CTMP is phosphorylated in 
vivo following stimulation of CCL64 cells with per-
vanadate. CCL64 cells expressing Flag-CTMP were meta-
bolically labeled with 32Pi prior to pervanadate treatment. (A) 
Immunoprecipitated 32P-labeled CTMP and (B) Extracted 
protein from both conditions was hydrolyzed and analyzed as 
described in Experimental Procedures. (Phosphoserine: pS, 
phosphothreonine: pT, and phosphotyrosine: pY) (C) Full 
scan mass spectrum of fraction 16 in the positive mode was 
acquired. (D) m/z values of the phosphopeptides were identi-
fied by m/z 79 precursor-ion scanning in the negative ion 
mode. (E and F). Tandem mass spectra derived by CID of the 
(M + 2H) 2+ precursor, m/z 609.3. Fragment ions in the 
spectra represent many single-event preferential cleavages of 
peptide bonds, resulting in the sequence information 
recorded from both the N- and C-termini of the peptide 
simultaneously. The single-letter code for the amino acids is 
shown.
Functional mitochondrial localization of CTMP Figure 2
Functional mitochondrial localization of CTMP. U2OS 
cells were transfected with (A) CTMP GFP-tagged at the N-
terminus (GFP-NT-CTMP) or (B) CTMP GFP-tagged at the 
C-terminus (GFP-CT-CTMP) for 24 h. Differential localiza-
tion of CTMP (Cyt: cytoplasm, PM: plasma membrane, Mit: 
mitochondria, Nuc: Nucleus) was examined using confocal 
microscopy. At least 200 cells were counted from three dis-
tinct fields for each transfected group. U2OS cells were co-
transfected with (C) pEGFP-N3-CTMP and pDsRed-mito for 
24 h and analyzed by confocal microscopy. (D) U2OS cells 
were transfected with pEGFP-N3-CTMP. Total lysates (Tot), 
cytosolic fractions (Cyt), and mitochondrial fractions (Mit) 
were analyzed by immunoblot analysis. (E) The subcellular 
fractions of HEK 293 cells were analyzed with the indicated 
antibodies. (COX IV, Mit marker; α-tubulin, Cyt marker). (F) 
Mitochondrial fractions of HEK 293 cells were isolated and 
treated under the indicated conditions. Samples were sepa-
rated into the supernatant (S) and precipitate (P) fractions 
and then analyzed. (AIF, Mit intermembrane space marker).BMC Cell Biology 2009, 10:53 http://www.biomedcentral.com/1471-2121/10/53
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iments to date were performed using an overexpression
system, we examined the subcellular localization of
endogenous CTMP in HEK293 cells. Immunoblot analy-
sis confirmed endogenous CTMP was localized at the
mitochondria as well as in the cytoplasm (Figure 2E). To
determine the precise localization of CTMP in mitochon-
dria, we first isolated mitochondria fractions which were
isolated under the following conditions: i) 2 M NaCl for
mitochondria outer membrane, ii) 100 mM Na2CO3for
intermembrane space and/or mitochondrial matrix and
iii) 1% (v/v) Triton X-100 for mitochondria inner or outer
membrane protein. CTMP was solubilized in Na2CO3
(Figure 2F), indicating that CTMP is a soluble protein in
either the inter-membrane space and/or the mitochon-
drial matrix.
Mitochondrial targeting sequence-mediated 
mitochondrial localization of CTMP is inhibited by 
phosphorylation event
Bioinformatics analysis of CTMP sequence using MitoProt
II 1.0a4 [22] predicted the mitochondrial signal peptide
could be cleaved at amino acid position 32, closed to the
identified phosphorylation site. In order to investigate the
potential mitochondrial targeting sequence (MTS) of
CTMP, an N-terminal 31-amino acid deletion-mutant of
CTMP (GFP-CT-CTMP ΔN31) was constructed based on
the prediction of MitoProt II 1.0a4 [22]. As predicted, this
mutant form of CTMP did not localize to the mitochon-
dria (Figure 3A and 3B). Since Ser37 and Ser38 of CTMP
were identified as in vivo phosphorylation sites (Figure 1E
and 1F), a negatively charged side group-mimic CTMP
mutant (GFP-CT-CTMP S37D/S38D) was generated. Con-
focal analysis of cells expressing this negatively charged
side group-mimic CTMP mutant showed that the majority
of cells expressed CTMP in the cytoplasm (Figure 3C; 93%
cytoplasm and 7% cytoplasm and plasma membrane),
suggesting phosphorylation on Ser37/Ser38 is an impor-
tant regulatory mechanism for CTMP shuttling to the
mitochondria.
CTMP overexpression sensitizes the cell to apoptosis 
induced by staurosporine
To evaluate the apoptotic role of CTMP, we overexpressed
CTMP in HeLa cells for 24 h and subsequently treated the
cells with 1 μM staurosporine for the indicated times.
Stauroporine-mediated apoptosis (assessed by PARP
cleavage and Caspase 3/9 activation) was detected at 3 h
of treatment (Figure 3D–3F, data not shown). Apoptosis
was more pronounced in CTMP-transduced compared to
controls, suggesting that CTMP overexpression increases
the sensitivity of cells to programmed cell death.
CTMP-mediated Hsp70 sequestration leads to the 
dissociation of Hsp70 and Apaf-1
Recent studies show that heat-shock proteins (Hsps) fam-
ily, including Hsp90, Hsp70 and Hsp27, can influence
apoptosis through direct physical interaction with key
components of the apoptotic machinery [24]. Since
CTMP overexpression appears to enhance the stau-
rosporine-induced apoptosis (Figure 3D–3F), the possible
interaction of CTMP with these Hsp proteins was moni-
tored in HeLa cells expressing HA-CTMP. Immunoprecip-
itation of HA-CTMP revealed that Hsp70 interacts with
CTMP while Hsp90 displayed negligible binding with
CTMP (Figure 4A), suggesting that this binding of CTMP
MTS- and phosphorylation-dependent mitochondria localiza- tion of CTMP in U2OS cells Figure 3
MTS- and phosphorylation-dependent mitochondria 
localization of CTMP in U2OS cells. U2OS cells were 
transfected with (A) An N-terminal deletion mutant of 
CTMP (GFP-CT-CTMP ΔN31) or (C) The S37D/S38D nega-
tively charged side group-mimic mutant form of CTMP (GFP-
CT-CTMP-S37D/S38D) for 24 h. Differential localization of 
CTMP (Cyt: cytoplasm, PM: plasma membrane, Mit: mito-
chondria, Nuc: Nucleus) was examined using confocal micro-
scopy. At least 200 cells were counted from three distinct 
fields for each transfected group. U2OS cells were co-trans-
fected with (B) pEGFP-N3-Δ31-CTMP and pDsRed-mito for 
24 h and analyzed. (D) HeLa cells were transduced with the 
indicated virus for 24 h, treated with 1 uM staurosporine for 
3 and 6 h, harvested, and analyzed. Results are representative 
of three independent experiments. (E, F) Bands of cleaved 
PARP and caspase 9 were further analyzed by densitometry. 
Statistical differences of cleaved protein were determined by 
comparing values for actin at each lane. The results are mean 
± SD of three independent experiments. Asterisk, p < 0.05; 
double asterisk, p < 0.01.BMC Cell Biology 2009, 10:53 http://www.biomedcentral.com/1471-2121/10/53
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and Hsp70 is specific. Furthermore, endogenous associa-
tion of CTMP and Hsp70 was also observed (Figure 4B).
Since Hsp70 is able to directly inhibit caspase processing
by interacting with Apaf-1 to prevent the recruitment of
procaspase-9 to the apoptosome [25,26], the interaction
between Hsp70 and Apaf-1 was monitored in HeLa cells.
The association of Hsp70 to Apaf-1 is significantly
reduced in CTMP-infected cells compared to control (Fig-
ure 4C). Taken together, CTMP is able to enhance apopto-
sis process by sequestering Hsp70 thus preventing its
binding to Apaf-1.
Discussion
Mitochondria are essential organelles in most eukaryotic
cells and function in the maintenance of cellular energy
supplies. Mitochondria are responsible for thermoregula-
tion and synthesis of essential molecules [14]. In addi-
tion, mitochondria also participate in key signaling events
regulating cell proliferation and death [27]. PKB has a crit-
ical role in regulating apoptosis [28-30] and directly phos-
phorylates and interacts with key factors involved
apoptosis signaling [30,31]. PKB also indirectly regulates
apoptotic transcription factors such as FOXO3a and NFκB
[30]. Additionally, activated PKB is localized to various
subcellular compartments including the mitochondria
and nucleus [32]. Therefore, there is a complex interplay
between PKB signaling and mitochondria-mediated
apoptosis.
We provide the first evidence that CTMP, a negative regu-
lator of PKB, localizes to the mitochondria in a MTS-
dependent manner (Figure 3A and 3B). We found CTMP
is located at the mitochondrial intermembrane space and/
or matrix (Figure 2D–2F). In addition, we discovered
CTMP is phosphorylated on Ser37/Ser38 (Figure 1) and
phosphorylation on these residues inhibited CMTP mito-
chondrial localization (Figure 3C). Furthermore, adenovi-
rus-mediated CTMP overexpression sensitized cells to
staurosporine-stimulated apoptosis (Figure 3D–3F).
Interestingly CTMP interacts with Hsp70, resulting the
sequestration of Hsp70 from Apaf-1 (Figure 4). Taken
together, these data suggest CTMP is a novel mitochon-
drial protein and is involved in apoptosis (Figure 4D).
Evidence suggest that CTMP negatively regulates PKB
activity in v-Akt transformed cells [10], ciliary ganglion
neurons [11], and K-ras-induced lung cancer model [12].
This observation is further supported by a recent report
showing epigenetic down-regulation of CTMP transcrip-
tion in malignant glioblastomas [13]. As previously sug-
gested [10], CTMP is phosphorylated in vivo in response to
pervanadate stimulation (Figure 1). In the current study,
two serine residues on CTMP that are phosphorylated in
response to pervanadate in vivo were identified (Figure 1).
Ser37/Ser38 is located at the amino-terminus of CTMP,
close to the putative MTS, as predicted by MitoProt II
1.0a4 [22]. These two seine residues are conserved in
CTMP homologues from mouse (NP_03707.1), rat
(NP_001020188.1) and dog (NP_001074103.1) but
lower organisms such as D. melanogaster, S. cerevisiae, S.
pombe or C. elegans do not appear to contain a gene for
CTMP, suggesting CTMP is a relatively recent protein dur-
Binding of CTMP to Hsp70 inhibits the formation of a com- plex containing Hsp70 and Apaf-1 in HeLa cells Figure 4
Binding of CTMP to Hsp70 inhibits the formation of a 
complex containing Hsp70 and Apaf-1 in HeLa cells. 
(A) HeLa cells were transiently transfected with HA-CTMP 
and cultured for 24 h. Bound proteins in HA-CTMP immuno-
precipitates were detected using anti-Hsp70 and anti-Hsp90 
antibodies (top two panels). (B) HeLa cell extracts were 
incubated with anti-CTMP antibody and bound Hsp70 was 
assessed by immunoblotting (top panel). (C) HeLa cells were 
infected with GFP- and CTMP-adenovirus for 24 h. After 
immunoprecipitation of Apaf-1, bound Hsp70 was detected 
(top panel). Input of each protein was also detected (bot-
tom). Similar results were obtained in three separate experi-
ments. (D) In addition to CTMP's role in PKB inhibition, 
CTMP has a key role in mitochondria-mediated apoptosis by 
localizing to mitochondria. CTMP appeared to be phosphor-
ylated on Ser37/Ser38 in response to pervanadate stimula-
tion, resulting in the cytosolic localization of CTMP. In this 
context, CTMP sensitizes the cell to apoptosis by binding to 
Hsp70, thus preventing its binding to Apaf-1. Therefore, 
CTMP may have distinct roles in various subcellular compart-
ments.BMC Cell Biology 2009, 10:53 http://www.biomedcentral.com/1471-2121/10/53
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ing evolution and the two identified serine residues might
be important for its function. In addition, Ser37 was pre-
dicted by the motif prediction program (Prosite) to be
phosphorylated by Casein kinase II. However, this possi-
bility needs to be experimentally evaluated in the context
of apoptosis and will provide detailed insight into CTMP
regulation.
CTMP was detected in the membrane and cytosol fraction
of LN229 cells [10]. Furthermore, two molecular species
corresponding to CTMP were observed in different cell
lines, suggesting post-translational modifications. In
addition, CTMP associated with intracellular structures
similar to membrane ruffles [10]. Recently, a nuclear pool
of CTMP was detected in human pancreatic duct epithelial
cells [33]. Consistent with recent reports [17], a mito-
chondrial pool of CTMP from HEK 293 cells dependent
on its MTS was detected in our experiments (Figure 2 and
3). Furthermore, this mitochondrial CTMP localization
was inhibited by phosphorylation (Figure 3C). Therefore,
CTMP may have distinct roles in various subcellular com-
partments.
Mitochondrial localization is mediated by the MTS. In
most cases, the MTS is present as a cleavable sequence at
the N terminus, also called a pre-sequence [23]. Bioinfor-
matic analysis of the CTMP sequence indicated that a
potential MTS exists in CTMP at the N-terminus of pro-
tein. This predicted N-terminal MTS appears to be func-
tional since an N-terminal 31-amino acid deletion-
mutant of CTMP did not localize to the mitochondria
(Figure 3A and 3B). N-terminal MTS of mitochondrial
precursors are in most cases cleaved by the mitochondrial-
processing peptidase (MPP) as soon as the cleavage sites
reach the mitochondrial matrix [34,35]. Mutational stud-
ies show the R-2 or R-3 motif are important but not suffi-
cient to direct cleavage by MPP [35]. Site-directed
mutagenesis of the -2 or -3 arginine in different precursor
molecules completely or partially inhibits processing
[36,37]. Further studies are needed to interrogate if the R-
2 motif of CTMP is important in MTS-mediated mito-
chondria localization.
The molecular pathways that mediate apoptosis are
tightly regulated by a series of positive and negative sig-
nals, the balance of which determines whether or not cells
commit suicide [38]. Recent evidence indicates that the
coordinated interaction between Hsps and the compo-
nents of apoptosis machinery may determine cellular sus-
ceptibility to damaging stresses [24]. Indeed, CTMP
associate specifically Hsp70, but not Hsp90, in HeLa cells
(Figure 4A and 4B). Furthermore, complex formation of
Hsp70 and Apaf-1 was decreased in CTMP-infected cell
compared to controls (Figure 4C), indicating why CTMP
overexpression sensitized the cell to apoptosis induced by
staurosporine (Figure 4D). Indeed, Miyawaki and col-
leagues recently reported that upregulation of CTMP in
hippocampal neurons is required for ischemia-induced
neuronal death [39]. Based on previous studies
([10,12,40], CTMP phosphorylation event occurs at the
plasma membrane in response to activation of growth fac-
tor signaling, leading to the release of PKB. In the case of
apoptosis, phosphorylation of the mitochondria pool of
CTMP by as-yet-unidentified kinase will promote the
exclusive cytoplasmic localization of CTMP, resulting the
sequestration of Hsp70 from Apaf-1. One can also pro-
posed that 14-3-3 may bind the phosphorylated CTMP
and maintain it's cytoplasmic localization. In this regard,
it will be of course interesting to discover how phosphor-
ylation affects the interaction between CTMP and Hsp70.
Further studies are required to elucidate mechanisms of
CTMP-dependent apoptosis under pathophysiological
conditions.
Conclusion
In summary, this work provides the first evidence for the
involvement of phosphorylation in the MTS-mediated
mitochondrial localization of CTMP. In addition to its
role in PKB inhibition, CTMP has a key role in mitochon-
dria-mediated apoptosis by localizing to mitochondria.
Whether phosphorylation of these serine residues affects
CTMP protein-protein interactions remains unknown.
Further analysis is likely to elucidate additional CTMP reg-
ulatory mechanisms, which will provide a better under-
standing of its role in signaling and its potential in
therapeutic applications.
Methods
Reagents
The anti-CTMP antibody used was described previously
[10]. Antibodies were purchased from the following com-
panies: anti-AIF and anti-COX IV (Cell Signaling), anti-
GFP (Santa Cruz Biotech), anti-PARP (BD Biosciences),
anti-Flag (Sigma), HRP-conjugated anti-mouse IgG (Cal-
biochem), HRP-conjugated anti-rabbit IgG (Calbio-
chem), and HRP-conjugated anti-sheep IgG antibody
(Sigma). Staurosporine and sodium orthovanadate
(Na3VO4) were purchased from Sigma.
Construction of expression vectors
GFP-N-terminal-tagged CTMP (GFP-NT-CTMP) was pre-
viously reported [10]. GFP-C-terminal-tagged CTMP
(GFP-CT-CTMP) was subcloned into pEGFP-N3
(Clonetech). CTMP deletion mutants were constructed in
pEGFP-N1 vector (GFP-CT-CTMP-ΔN31). Ser37/Ser38
negatively charged side group-mimic mutants (S37D/
S38D) were created by using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene), using pEGFP-N3-
CTMP as a template. An adenoviral CTMP vector in
pENTR-3C was prepared using the Adenoviral ExpressionBMC Cell Biology 2009, 10:53 http://www.biomedcentral.com/1471-2121/10/53
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Kit (Invitrogen). Adenoviruses were purified as described
previously [41]. Constructs were confirmed by DNA
sequencing. Mutagenic and cloning oligonucleotide
sequences are available upon request.
Cell culture and stimulation
U2OS, CCL64, HeLa, and HEK 293 cells were maintained
in Dulbecco's modified Eagle's medium (DMEM) supple-
mented with 10% FBS, 2 mM glutamine, 100 unit/ml
penicillin, and 100 μg/ml streptomycin (Life Technolo-
gies) and were transfected using FuGene 6 (Roche), jetPEI
(Q-biogene), or Lipofectamine (Invitrogen) reagent. The
transfection mixture was removed after 24 h and cells
were serum-starved for 16 h before stimulation for 15 min
with 100 μM pervanadate, prepared in 0.2 mM H2O2 [42].
To induce apoptosis, cells were treated with 1 mM stau-
rosporine for the indicated time.
In vivo labeling of stable CCL64 cells expressing wild type 
Flag-CTMP and phosphoamino acid analysis
Metabolic labeling of CCL64 cells was performed as
described previously, with minor modifications [43].
Briefly, cells were stimulated with buffer or 100 μM per-
vanadate for 15 min. The 32P-labeled band corresponding
to Flag-CTMP was excised, reduced, alkylated, and cleaved
with 1 μg of trypsin (Promega, sequencing grade). Phos-
phoamino acids were identified following hydrolysis in 6
M HCl containing 0.1 mg/ml bovine serum albumin at
110°C for 60 min. Hydrolysates were separated by thin
layer electrophoresis at pH 3.5 to resolve phosphoserine
(pS), phosphothreonine (pT), and phosphotyrosine (pY)
[44]. Radioactivity was detected using a PhosphoImager
(Molecular Dynamics).
Phosphorylation site mapping by mass spectrometry
Extracted peptides were analyzed by high-performance
liquid chromatography (HPLC) interfaced with electro-
spray ionization mass spectrometry (ESI-MS), using a
Rheos 4000 chromatograph equipped with a 1 × 250 mm
Vydac (Hesperia) C18 column and interfaced with a Sciex
API 300 mass spectrometer (PE Sciex), operated in the sin-
gle quadrupole mode on Q1. Analysis of mass spectra of
phosphopeptides was performed as described previously
[43]. Mass spectra were acquired on a Sciex API 300 triple
quadrupole mass spectrometer equipped with a NanoESI
source (Protana).
Confocal imaging analysis of CTMP localization
U2OS cells were grown on glass coverslips and transfected
with GFP-CTMP or pDsRed-Mito, a mitochondrial
marker. After 24 h, cells were fixed in 4% paraformalde-
hyde at room temperature for 10 min, mounted with
Vectashield (Vector Laboratories) and visualized using a
OLYMPUS 510 confocal microscope. Differential locali-
zation of CTMP (Cyt: cytoplasm, PM: plasma membrane,
Mit: mitochondria, Nuc: Nucleus) was examined using
confocal microscopy. At least 200 cells were counted from
three distinct fields for each transfected group.
Preparation of mitochondria and plasma membranes
Cells were washed with PBS and resuspended in mito-
chondrial fraction buffer (20 mM HEPES, pH 8.0, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, 250 mM sucrose, 1 mM
PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, and 0.2 mM
sodium orthovanadate) for 30 min on ice and then
homogenized. Unbroken cells and nuclei were removed.
The supernatant was centrifuged at 10,000 × g for 30 min
at 4°C. The resultant supernatant, representing the
cytosolic fraction, was centrifuged at 100,000 × g for 1 h
at 4°C. The resultant pellet was washed with 500 μl of
mitochondrial fraction buffer and solubilized in lysis
buffer to generate the mitochondrial fraction. Isolated
mitochondrial fractions were further treated with 2 M
sodium chloride, 100 mM sodium carbonate (pH 11.2),
or 1% Triton X-100 for 30 min. Samples were ultracentri-
fuged at 100,000 × g for 1 h to separate the supernatant
(S) and precipitate (P) fractions.
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